According to Lianya Pharmaceutical's announcement, the company's application for an initial public offering of shares and listing on the GEM has been reviewed and approved by the internal board of directors and the 3rd Extraordinary General Meeting of Shareholders in 2025. The Shenzhen Stock Exchange has obtained approval for registration from the China Securities Regulatory Commission. The Shenzhen Stock Exchange has issued a notice agreeing to list the company's shares on the GEM. The stock code is “Lianya Pharmaceutical” for short, and the stock code is “301569.” The total share capital of the company before the issuance was 758 million yuan, and the total share capital after issuance was 892 million yuan. The total net profit returned to mother in the last two years was 404 million yuan, which met the actual requirements for listing on the GEM.

Disclaimer:Webull uses external vendor Google Translation Service for news translations where we endeavour to ensure these are correct, however, we recommend that you please double-check this information accordingly. Webull is not responsible for translation errors or issues.